Posters on AN1 are asking is the HNG influence questionable on management of its virtual subsidiary Anagenics Ltd (AN1) and whether it’s a factor behind the businesses continuing losses and collapse in the share price.
To what extent is the incumbent AN1 CEO and MD accountable to the hierarchy at HNG and directed by their obsession with errant M&A deals ?
Is the AN1 Board independent enough to adequately act in the best interest of AN1 shareholders?
Are HNG director(s) being paid by AN1 (cash and/or AN1 shares?) for giving advice to the AN1 CEO and MD? If so, explain how and why and discloses a copy of the agreement.
Posters on AN1 are asking is the HNG influence questionable on...
Add HNG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.3M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 91117 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 87537 | 4 |
View Market Depth
| Last trade - 09.10am 18/06/2024 (20 minute delay) ? |
| HNG (ASX) Chart |
Day chart unavailable
